Guoyin Yin

Dr. Guoyin Yin


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2025 in Organics
Verified
Journal Article
Open access
PDF file
PFPedro Daniel Gordon Almeida Freitas
Pedro Daniel Gordon Almeida Freitas
DMDina Maciel
Dina Maciel
Jolanta JaskowskaJolanta Jaskowska
Jolanta Jaskowska
KZKamila Zeńczak-Tomera
Kamila Zeńczak-Tomera
YZYanbiao Zhou
Yanbiao Zhou
RSRuilong Sheng
Ruilong Sheng
Developing new biomolecule–drug conjugates as prodrugs is a promising area for natural products and pharmaceutical chemistry. Herein, a cholesterol–doxorubicin (Chol-DOX) conjugate was synthesized using cholesteryl-4-nitrophenolate as a facile, stable, and controllable activated ester. This approach offers an alternative to the conventional HCl-emitting cholesteryl chloroformate method. Semi-empirical theoretical calculations showed that cholesteryl-4-nitrophenolate exhibits moderate reactivity, greater thermodynamic stability, a higher dipole moment, and a lower HOMO-LUMO energy gap compared to cholesteryl chloroformate, suggesting that cholesteryl-4-nitrophenolate could be used as a more controllable acylating agent. The structure of the synthesized Chol-DOX conjugate was characterized using NMR, MS, and FT-IR techniques. Biological properties of the Chol-DOX conjugate were analyzed with a comparison of theoretical and experimental data. This work provides a facile and controllable method to synthesize natural lipid–DOX prodrugs and offers an in-depth data analysis of the related biological properties.


19 November 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
PFPedro Daniel Gordon Almeida Freitas
Pedro Daniel Gordon Almeida Freitas
DMDina Maciel
Dina Maciel
Jolanta JaskowskaJolanta Jaskowska
Jolanta Jaskowska
KZKamila Zeńczak-Tomera
Kamila Zeńczak-Tomera
YZYanbiao Zhou
Yanbiao Zhou
RSRuilong Sheng
Ruilong Sheng
Developing new biomolecule-drug conjugates as prodrugs is a promising area for natural products and pharmaceutical chemistry. Herein, a cholesterol-doxorubicin (Chol-DOX) conjugate was synthesized using cholesteryl-4-nitrophenolate as a facile, stable, and controllable activated ester. This approach offers an alternative to the conventional HCl-emitting cholesteryl chloroformate method, semi-empirical theoretical calculations showed that cholesteryl-4-nitrophenolate exhibits moderate reactivity, higher thermodynamic stability, and a lower HOMO-LUMO energy gap compared to cholesteryl chloroformate, suggesting cholesteryl-4-nitrophenolate could be used as a more controllable acylating agent. The structure of synthesized Chol-DOX conjugate was characterized using NMR and MS techniques. Biological properties of the Chol-DOX were analyzed with the comparison of theoretical and experimental data. This work provided a facile and controllable method to synthesize natural lipid-DOX prodrug and offered an in-depth data analysis of the related biological properties.